Insufficient scRNA-seq data for expression of DRAXIN at single-cell level.
Insufficient scRNA-seq data for expression of DRAXIN at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 97% | 240.24 | 2552 / 2642 | 97% | 11.44 | 686 / 705 |
peripheral blood | 89% | 136.83 | 825 / 929 | 0% | 0 | 0 / 0 |
spleen | 85% | 43.34 | 205 / 241 | 0% | 0 | 0 / 0 |
kidney | 69% | 30.62 | 61 / 89 | 8% | 0.34 | 70 / 901 |
lung | 63% | 34.27 | 366 / 578 | 11% | 0.28 | 131 / 1155 |
breast | 39% | 15.17 | 180 / 459 | 30% | 0.85 | 333 / 1118 |
skin | 32% | 11.30 | 572 / 1809 | 29% | 2.60 | 139 / 472 |
thymus | 9% | 2.78 | 58 / 653 | 51% | 1.30 | 307 / 605 |
uterus | 12% | 3.40 | 21 / 170 | 33% | 1.55 | 153 / 459 |
intestine | 39% | 12.45 | 372 / 966 | 6% | 0.11 | 29 / 527 |
prostate | 31% | 10.21 | 77 / 245 | 3% | 0.04 | 16 / 502 |
esophagus | 10% | 2.93 | 149 / 1445 | 16% | 0.66 | 30 / 183 |
ovary | 12% | 10.49 | 21 / 180 | 15% | 0.40 | 63 / 430 |
adipose | 24% | 8.28 | 291 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 20% | 0.36 | 9 / 45 |
bladder | 5% | 1.14 | 1 / 21 | 14% | 0.68 | 71 / 504 |
heart | 14% | 4.95 | 124 / 861 | 0% | 0 | 0 / 0 |
pancreas | 2% | 0.68 | 8 / 328 | 12% | 0.29 | 21 / 178 |
stomach | 4% | 1.17 | 16 / 359 | 7% | 0.24 | 21 / 286 |
lymph node | 0% | 0 | 0 / 0 | 10% | 0.16 | 3 / 29 |
blood vessel | 10% | 3.88 | 134 / 1335 | 0% | 0 | 0 / 0 |
liver | 3% | 0.94 | 6 / 226 | 1% | 0.04 | 3 / 406 |
adrenal gland | 2% | 0.64 | 4 / 258 | 1% | 0.04 | 3 / 230 |
muscle | 1% | 0.31 | 9 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0021516 | Biological process | dorsal spinal cord development |
GO_0030517 | Biological process | negative regulation of axon extension |
GO_0016055 | Biological process | Wnt signaling pathway |
GO_0021960 | Biological process | anterior commissure morphogenesis |
GO_0110088 | Biological process | hippocampal neuron apoptotic process |
GO_0110091 | Biological process | negative regulation of hippocampal neuron apoptotic process |
GO_0090090 | Biological process | negative regulation of canonical Wnt signaling pathway |
GO_0021528 | Biological process | commissural neuron differentiation in spinal cord |
GO_0007411 | Biological process | axon guidance |
GO_0030900 | Biological process | forebrain development |
GO_0005576 | Cellular component | extracellular region |
GO_0005515 | Molecular function | protein binding |
GO_0060090 | Molecular function | molecular adaptor activity |
Gene name | DRAXIN |
Protein name | Draxin (Dorsal inhibitory axon guidance protein) (Dorsal repulsive axon guidance protein) (Neucrin) |
Synonyms | PSEC0258 C1orf187 UNQ3119/PRO10268 |
Description | FUNCTION: Chemorepulsive axon guidance protein required for the development of spinal cord and forebrain commissures. Acts as a chemorepulsive guidance protein for commissural axons during development. Able to inhibit or repel neurite outgrowth from dorsal spinal cord. Inhibits the stabilization of cytosolic beta-catenin (CTNNB1) via its interaction with LRP6, thereby acting as an antagonist of Wnt signaling pathway. . |
Accessions | ENST00000294485.6 Q8NBI3 |